Support info of Preliminary clinical observation of efficacy and safety of stereotactic body radiation therapy in combination with targeted therapy for metastatic renal cell carcinoma

中华放射肿瘤学杂志


	2020, Vol. 29(10): 855-858 DOI: 10.3760/cma.j.cn113030-20190805-00314

	Preliminary clinical observation of efficacy and safety of stereotactic body radiation therapy in combination with targeted therapy for metastatic renal cell carcinoma
	Liu Yang¹, Dong Pei², Huang Sijuan¹, Cao Wufei¹, Liu Boji¹, Lin Maosheng¹, Jiang Xiaobo¹, Lin Chengguang¹, Liu Zhuowei², Han Hui², Li Yonghong², Liu Mengzhong¹, Zhou Fangjian², He Liru¹
	¹Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; ²Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
	Received 2019-08-05 Revised null
	Supporting info